601
Participants
Start Date
January 31, 2024
Primary Completion Date
October 2, 2024
Study Completion Date
February 20, 2025
AEYE-DS Software
An Artificial Intelligence (AI) software device to be used as a diagnostic tool to assist healthcare providers in screening for diabetic retinopathy (DR) using digital funduscopic images. The device automatically detects more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with DR.
Clinical Trial Network, Houston
Lead Sponsor
Collaborators (1)
A. Stein Regulatory Affairs Consulting Ltd.
UNKNOWN
AEYE Health Inc
INDUSTRY